ISD11 Antibody

What is ISD11 and what cellular functions does it perform?

ISD11 (also known as LYRM4) is a member of the LYR family of proteins that contain a conserved tripeptide 'LYR' near the N-terminus. It functions as an essential component in iron-sulfur (Fe-S) cluster biogenesis, forming a stable complex with the cysteine desulfurase (ISCS), which generates the inorganic sulfur required for Fe-S protein assembly . The functional significance of ISD11 has been demonstrated through RNA interference studies, where suppression of human ISD11 resulted in inactivation of mitochondrial and cytosolic aconitases, activation of iron-responsive element-binding activity of iron regulatory protein 1, increased protein levels of iron regulatory protein 2, and abnormal punctate ferric iron accumulations in cells . These effects highlight ISD11's critical role in maintaining proper iron homeostasis across cellular compartments. Additionally, ISD11 has been shown to interact with frataxin, a protein associated with Friedreich's ataxia, suggesting its involvement in pathways relevant to this neurodegenerative disease .

Where is ISD11 localized in human cells and how can this be visualized?

Human ISD11 demonstrates a dual localization pattern in cells, being present in both mitochondrial and nuclear compartments. This localization profile has been established through multiple complementary techniques. Immunofluorescence confocal microscopy using affinity-purified polyclonal rabbit anti-human ISD11 antibody reveals that endogenous ISD11 predominantly localizes to nuclei and mitochondria, with some cytosolic presence . When visualized alongside mitochondrial markers like Tom20, clear colocalization of ISD11 within mitochondria is evident. Nuclear localization is confirmed through DAPI co-staining .

This dual localization has been further verified through subcellular fractionation studies, which demonstrate the presence of ISD11 in both nuclear extracts and mitochondrial fractions . Interestingly, the cysteine desulfurase ISCS, which forms a complex with ISD11, shows a similar localization pattern, being robustly detected in the nucleus with a distribution resembling that of ISD11, particularly with notable absence in discrete punctate areas that likely represent nucleoli . When designing experiments to visualize ISD11, researchers should employ both immunofluorescence and subcellular fractionation approaches to comprehensively document its distribution patterns.

What controls should be included when using ISD11 antibodies in immunoprecipitation experiments?

When conducting immunoprecipitation experiments with ISD11 antibodies, several critical controls should be incorporated to ensure experimental validity and interpretability. First, a non-specific IgG control from the same species as the ISD11 antibody is essential to assess non-specific binding . This control helps distinguish genuine interactions from background signal. As demonstrated in published research, IgG controls consistently show no detectable signal when compared to specific antibody immunoprecipitations .

Second, reciprocal co-immunoprecipitation should be performed to validate protein-protein interactions. For example, when studying the ISD11-ISCS complex, immunoprecipitation should be conducted both with anti-ISD11 antibody (followed by western blotting with anti-ISCS antibody) and with anti-ISCS antibody (followed by western blotting with anti-ISD11 antibody) . This bidirectional validation strengthens confidence in the observed interaction.

Third, when studying interactions with tagged proteins, parallel experiments with untagged endogenous proteins should be performed to confirm that interactions are not artifacts of protein overexpression or tag interference . For instance, studies have demonstrated that endogenous frataxin can be immunoprecipitated with ISD11-flag protein, confirming that this interaction occurs naturally and is not solely a consequence of protein overexpression .

How can ISD11 antibodies be used to study protein interactions in different cellular compartments?

ISD11 antibodies can be strategically employed to investigate protein interactions occurring in distinct cellular compartments through a multi-faceted experimental approach. For mitochondrial interactions, researchers should first isolate intact mitochondria using differential centrifugation techniques followed by lysis under conditions that preserve protein-protein interactions. Immunoprecipitation with anti-ISD11 antibodies from these mitochondrial lysates can then specifically capture mitochondrial ISD11 complexes . This compartment-specific approach has successfully demonstrated the interaction between endogenous frataxin and endogenous ISD11 within mitochondria .

For nuclear interactions, nuclear extraction protocols that maintain protein complex integrity should be employed prior to immunoprecipitation. When analyzing ISD11's interaction network across different compartments, subcellular fractionation quality should be rigorously verified using compartment-specific marker proteins, such as mitochondrial aconitase for mitochondria and appropriate nuclear markers . This verification ensures that observed interactions are genuinely compartment-specific rather than artifacts of cross-contamination.

Immunofluorescence co-localization studies serve as valuable complementary approaches, allowing visualization of potential interaction partners within specific subcellular locations. For instance, co-expression of flag-tagged ISD11 and HA-tagged frataxin followed by dual-color immunofluorescence has been used to demonstrate their co-localization in mitochondria . These visual methods provide spatial context that strengthens biochemical interaction data.

What methodological approaches are most effective for studying ISD11's role in Fe-S cluster assembly?

Investigating ISD11's function in Fe-S cluster assembly requires a multi-dimensional experimental strategy that combines genetic manipulation, biochemical analysis, and functional readouts. RNA interference (RNAi) techniques have proven particularly valuable, with studies achieving >70% reduction of ISD11 mRNA through three successive transfections of specific siRNA oligos . When designing such experiments, quantitative real-time PCR should be employed to accurately measure suppression efficiency at the transcript level, while western blotting confirms protein reduction .

The functional consequences of ISD11 depletion on Fe-S cluster biogenesis can be comprehensively assessed by measuring the enzymatic activities of Fe-S proteins. Aconitases (both mitochondrial and cytosolic forms) serve as sensitive indicators of Fe-S cluster assembly defects following ISD11 suppression . Additionally, the iron-responsive element-binding activity of iron regulatory protein 1 provides another functional readout, as this activity increases when ISD11 is suppressed .

For mechanistic studies of ISD11's role within the Fe-S assembly complex, co-immunoprecipitation experiments that capture interactions with other components, such as ISCS and frataxin, are essential . These should be combined with activity assays that directly measure sulfur transfer or cluster assembly rates. Researchers should also consider complementation experiments, where wild-type ISD11 is reintroduced following suppression to confirm phenotype rescue and establish causality.

How can researchers optimize western blot detection of endogenous ISD11?

Optimizing western blot detection of endogenous ISD11 presents several technical challenges due to its relatively low molecular weight (~11 kDa) and potentially varying expression levels across different cell types. Based on published experimental protocols, several optimization strategies are recommended. First, sample preparation should employ reducing conditions to ensure complete protein denaturation, as demonstrated in studies where a specific band for ISD11 was detected after proper sample treatment .

For gel electrophoresis, high percentage (15-18%) SDS-PAGE gels are advisable to achieve optimal resolution of low molecular weight proteins like ISD11. Transfer conditions should be carefully optimized for small proteins, potentially using semi-dry transfer systems with reduced methanol concentration buffers to prevent protein loss through the membrane .

When selecting primary antibodies, affinity-purified polyclonal antibodies have demonstrated high specificity for human ISD11 in western blot applications . Importantly, these antibodies should be validated to recognize both endogenous and transfected ISD11. Extended primary antibody incubation times (overnight at 4°C) may improve detection sensitivity for low-abundance proteins .

For visualization, enhanced chemiluminescence (ECL) systems with high sensitivity are recommended, particularly when detecting endogenous ISD11 in cells with low expression levels. Finally, proper loading controls should be included that are appropriate for the subcellular fraction being analyzed, such as mitochondrial or nuclear markers depending on the experimental context .

What experimental approaches can distinguish between ISD11's functions in mitochondria versus the nucleus?

Distinguishing between ISD11's compartment-specific functions requires sophisticated experimental designs that isolate and manipulate ISD11 in a location-specific manner. Subcellular fractionation followed by compartment-specific functional assays represents a foundational approach. Well-validated protocols that yield pure mitochondrial and nuclear fractions, confirmed through appropriate marker proteins, are essential prerequisites .

Targeted genetic manipulation can be achieved through the expression of ISD11 variants containing modified targeting sequences. For example, constructs with mutated mitochondrial targeting signals but preserved nuclear localization would enable selective study of nuclear functions. Conversely, adding a strong nuclear export signal could enhance mitochondrial accumulation. The effectiveness of these targeting manipulations should be verified through immunofluorescence microscopy and subcellular fractionation .

Proximity-dependent labeling techniques, such as BioID or APEX2 fused to ISD11, offer another approach for identifying compartment-specific interaction partners. By expressing these constructs with appropriate localization signals, researchers can selectively label proteins that interact with ISD11 in either mitochondria or nuclei.

Additionally, rescue experiments in ISD11-depleted cells using compartment-restricted ISD11 variants can reveal the relative contribution of mitochondrial versus nuclear ISD11 to specific cellular phenotypes. For instance, if expression of only mitochondria-targeted ISD11 restores aconitase activity, this would suggest that the mitochondrial pool of ISD11 is primarily responsible for this function .

How do ISD11 antibodies enable investigation of the frataxin-ISD11 interaction dynamics?

ISD11 antibodies facilitate detailed investigation of frataxin-ISD11 interaction dynamics through multiple complementary approaches. Co-immunoprecipitation experiments using anti-frataxin antibodies have successfully pulled down ISD11, and conversely, anti-flag antibodies (in cells expressing flag-tagged ISD11) have pulled down endogenous frataxin . These bidirectional co-immunoprecipitation results provide strong evidence for a genuine interaction between these proteins.

To address potential concerns about artifacts from protein overexpression, researchers have designed elegant experiments demonstrating that the frataxin-ISD11 interaction occurs between endogenous proteins. For example, anti-frataxin antibodies have been shown to immunoprecipitate flag-tagged ISD11 when no frataxin vector was transfected, confirming that endogenous frataxin interacts with ISD11 . Similarly, antibodies against endogenous frataxin have successfully immunoprecipitated endogenous ISD11 from mitochondrial lysates, as verified by western blotting with ISD11-specific antibodies .

For studying the spatial aspects of this interaction, dual-label immunofluorescence microscopy with anti-frataxin and anti-flag (for flag-tagged ISD11) antibodies has revealed co-localization patterns in cellular compartments . When designing such experiments, appropriate controls including single-transfected cells should be included to confirm antibody specificity.

Quantitative aspects of the interaction can be assessed through titration experiments where varying amounts of one protein are expressed against a constant level of the other, followed by co-immunoprecipitation and quantitative western blotting to determine binding stoichiometry and affinity.

What are the critical quality control measures for validating ISD11 antibodies?

Comprehensive validation of ISD11 antibodies requires multiple rigorous quality control measures to ensure specificity, sensitivity, and reproducibility. Antibody specificity should be assessed through western blot analysis of samples with manipulated ISD11 expression levels. In ideal validation experiments, the antibody should detect a single band of appropriate molecular weight (~11 kDa for human ISD11) that increases in intensity with overexpression and decreases or disappears following siRNA-mediated knockdown .

Cross-reactivity testing is essential, particularly when studying ISD11 in different species. Researchers should verify that the antibody recognizes recombinant ISD11 and does not cross-react with other LYR family proteins that share sequence homology. Peptide competition assays, where pre-incubation of the antibody with excess ISD11 peptide blocks signal detection, provide additional confirmation of specificity .

For immunoprecipitation applications, validation should demonstrate that the antibody efficiently captures ISD11 from cell lysates and co-precipitates known interaction partners such as ISCS . For immunofluorescence applications, the antibody's staining pattern should match the expected subcellular distribution of ISD11 in mitochondria and nuclei, and this pattern should be altered in predictable ways following ISD11 knockdown or compartment-specific targeting .

Lot-to-lot consistency testing is advisable for long-term studies, as antibody performance can vary between production batches. Finally, publication of detailed validation data alongside experimental results enhances research reproducibility and allows appropriate interpretation of antibody-based findings in the ISD11 field.

How can researchers troubleshoot non-specific binding in ISD11 immunoprecipitation experiments?

Non-specific binding in ISD11 immunoprecipitation experiments can compromise data interpretation but can be minimized through systematic troubleshooting approaches. First, optimize pre-clearing procedures by incubating cell lysates with protein A/G beads and non-specific IgG antibodies from the same species as the ISD11 antibody before performing the actual immunoprecipitation . This step removes proteins that bind non-specifically to the beads or antibody constant regions.

When analyzing co-immunoprecipitation results for protein-protein interactions, always include proper controls. IgG from the same species as the primary antibody serves as a negative control for non-specific binding . Additionally, include lysate-only controls (no antibody) to identify proteins that bind directly to the beads.

For particularly challenging samples, consider cross-linking the antibody to beads to prevent antibody heavy and light chains from appearing in the eluted samples. This modification is especially helpful when the protein of interest has a molecular weight similar to antibody chains. Finally, use specific elution techniques that minimize co-elution of non-specifically bound proteins, such as peptide competition or pH gradient elution rather than boiling in SDS-PAGE loading buffer.

What experimental design considerations are important for studying ISD11 in disease models?

Studying ISD11 in disease models requires careful experimental design that addresses both basic mechanistic questions and disease-relevant parameters. When establishing disease models, researchers should first characterize baseline ISD11 expression, localization, and function in the relevant cell types or tissues using validated antibodies . This characterization provides the foundation for identifying disease-associated alterations.

For genetic diseases linked to iron-sulfur cluster formation, such as Friedreich's ataxia, patient-derived cells or genetically modified cells that recapitulate the disease mutation are valuable models. In these systems, ISD11 antibodies can be used to assess whether disease mutations affect ISD11 expression, localization, or its interaction with proteins like frataxin . Co-immunoprecipitation experiments have already demonstrated that frataxin interacts with ISD11, suggesting that this interaction may be relevant to Friedreich's ataxia pathogenesis .

When designing suppression or overexpression experiments, researchers should carefully titrate the degree of manipulation to match disease-relevant levels rather than creating extreme conditions that may trigger secondary effects unrelated to the disease process. For instance, partial knockdown of ISD11 may better mimic disease states than complete elimination .

Functional readouts should include disease-relevant parameters. In iron homeostasis disorders, these might include aconitase activity, iron-responsive element-binding activity, iron regulatory protein levels, and iron distribution patterns . These parameters provide mechanistic insights into how ISD11 dysfunction contributes to disease phenotypes.

What are the best practices for quantifying ISD11-protein interactions using antibody-based techniques?

Quantitative analysis of ISD11-protein interactions requires rigorous methodological approaches that go beyond simple detection. For co-immunoprecipitation experiments, quantification should include both the target protein and the interacting partner, with results normalized to input levels to account for expression differences . Loading a standard curve of recombinant proteins can provide absolute quantification references.

When analyzing interaction dynamics, systematically vary experimental conditions such as oxidative stress, iron availability, or cell cycle stage to determine how these factors influence ISD11 interactions. Time-course experiments following stimulation or inhibition of relevant pathways can reveal the kinetics of complex formation and dissolution.

For comparing interaction strengths between different partners or conditions, competitive co-immunoprecipitation experiments can be informative. In this approach, two potential binding partners are co-expressed, and the relative amounts of each that co-precipitate with ISD11 indicate their relative affinities.

Microscopy-based approaches such as Förster resonance energy transfer (FRET) or proximity ligation assay (PLA) offer complementary quantitative information about ISD11 interactions in intact cells, including spatial information that is lost in biochemical assays. These techniques can be particularly valuable for distinguishing between interactions occurring in mitochondrial versus nuclear compartments .

Finally, emerging technologies such as BiFC (Bimolecular Fluorescence Complementation) allow visualization and quantification of specific protein-protein interactions in living cells and could be adapted to study ISD11 interactions with partners such as ISCS or frataxin in different cellular compartments.

ISD11 function shows both conservation and divergence across model organisms, with important implications for antibody selection and experimental design. In Saccharomyces cerevisiae, Isd11 was initially identified as an essential component of iron-sulfur cluster biogenesis, forming a complex with the cysteine desulfurase Nfs1 . Similarly, human ISD11 forms a stable complex with ISCS and plays a crucial role in Fe-S protein biogenesis .

When designing experiments with ISD11 antibodies across model organisms, researchers should verify antibody cross-reactivity through western blotting of lysates from each species. Sequence alignment of ISD11 proteins from different organisms can identify conserved and divergent epitopes that might affect antibody recognition. For immunofluorescence studies, the expected subcellular localization pattern should be verified in each model organism, as differences in targeting sequences may alter distribution .

Functionally, while ISD11's core role in Fe-S cluster biogenesis appears conserved, its interactions with other proteins may vary between species. Therefore, co-immunoprecipitation experiments identifying interaction partners should be performed specifically in the model organism of interest rather than extrapolating findings across species .